InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.93
(
1.15%
)
Bitcoin
70,193.24
(
2.46%
)
Post# of 21531
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whatsupp

Send PM Follow Ignore
Followers 4
Posts 1012
Boards Moderated 0
Alias Born 02/14/2017

Whatsupp

Re: runncoach post# 11773

Thursday, 06/27/2019 11:39:09 AM

Thursday, June 27, 2019 11:39:09 AM

Post# of 21531

Yes I agree, especially after Janney has predicted a 100% chance that the 2b results will be confirmed. ;)

"Ongoing Phase II Study Should Confirm Bryostatin’s Efficacy. ...

We believe the design of the ongoing Phase II study should support the exploratory findings from the previous Phase II study. The prespecified exploratory findings demonstrated significant improvement in SIB score compared to placebo at Week 13 and the average of Weeks 13 and 15 in patients who were not taking memantine. Upon confirmation of efficacy, Neurotrope plans to initiate a Phase III study in the same patient population (moderately severe to severe AD). "
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!